NHCI Suburban Hematology-oncology Associates - Duluth — Duluth, Georgia

NHCI Suburban Hematology-oncology Associates - Duluth is a clinical research site located in Duluth, Georgia, United States 30096.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NHCI Suburban Hematology-oncology Associates - Duluth has participated in 1 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NHCI Suburban Hematology-oncology Associates - Duluth?

NHCI Suburban Hematology-oncology Associates - Duluth has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NHCI Suburban Hematology-oncology Associates - Duluth conducted?

NHCI Suburban Hematology-oncology Associates - Duluth has 1 clinical trials on record. Their work covers HER2 Positive Breast Cancer.

Is NHCI Suburban Hematology-oncology Associates - Duluth accredited by Crixeo Health?

NHCI Suburban Hematology-oncology Associates - Duluth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NHCI Suburban Hematology-oncology Associates - Duluth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.